Augusta University · BiologyThe Glioblastoma Innovation Lab
Balveen Kaur · Augusta, Georgia
Research Focus
Dr. Balveen Kaur's lab at Augusta University focuses on developing innovative therapies to treat glioblastoma (GBM), a deadly brain cancer. The lab's primary research investigates the use of oncolytic herpes simplex virus (oHSV) in combination with strategies to block NOTCH signaling, which can enhance the virus's effectiveness against tumors while ensuring safety for brain function. By understanding how these pathways interact, the lab aims to improve treatment options for patients suffering from this challenging disease.
GlioblastomaOncolytic virusNOTCH signalingVirotherapyTumor immunity
Research Aims
3AIM 01Develop a NOTCH blocking strategy combined with oHSV for GBM treatment.
AIM 02Evaluate the effects of NOTCH ligand signaling on anti-tumor immunity.
AIM 03Create a safe oHSV that targets specific NOTCH signaling pathways.
Skills the Lab Values
Cell cultureMouse modelsMolecular cloningVirus engineeringFlow cytometry
Output against the department
Publications531top 7% of dept.74th of 1,033
this lab
most publishedleast published
Citations12ktop 30% of dept.311th of 1,033
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.